It took about three years but the first major international conference on long COVID – the “Keystone Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment” conference recently took place in Santa Fe, New Mexico at the El...
The “WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome” study is fraught with possibility. For one, it was published in The Proceedings of the National Academy of Sciences...
Bringing a new drug combination to market is not easy. First, it requires creativity and initiative. Dr. Skip Pridgen was nothing if not creative when he put together a two-drug combo antiviral (valacyclovir) and an anti-inflammatory with antiviral properties...
The kind of loopy name – alpha-gal syndrome – belies its significance. The alpha-gal syndrome is no joke and may even be mimicking diseases like post-treatment Lyme Disease, irritable bowel syndrome, mast cell activation syndrome (MCAS), orthostatic...
All eight of Health Rising’s recent recovery stories have featured different approaches thus far and so it goes with Amber’s story. Everything is different with Amber – she is different – and her pathway to wellness is different. Amber’s...
The great question for chronic fatigue syndrome and long COVID is: what causes post-exertional malaise (PEM)? The latest study to come out of Nancy Klimas’s Institute for Neuroimmune Medicine – led by Lubov Nathanson (senior author) and directed by Derek...